These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29154037)

  • 1. Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease.
    Roy U; Stute L; Höfling C; Hartlage-Rübsamen M; Matysik J; Roβner S; Alia A
    Neurobiol Aging; 2018 Feb; 62():168-179. PubMed ID: 29154037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bell-shaped dependence between amyloidosis and GABA accumulation in astrocytes in a mouse model of Alzheimer's disease.
    Brawek B; Chesters R; Klement D; Müller J; Lerdkrai C; Hermes M; Garaschuk O
    Neurobiol Aging; 2018 Jan; 61():187-197. PubMed ID: 29107186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease.
    Jo S; Yarishkin O; Hwang YJ; Chun YE; Park M; Woo DH; Bae JY; Kim T; Lee J; Chun H; Park HJ; Lee DY; Hong J; Kim HY; Oh SJ; Park SJ; Lee H; Yoon BE; Kim Y; Jeong Y; Shim I; Bae YC; Cho J; Kowall NW; Ryu H; Hwang E; Kim D; Lee CJ
    Nat Med; 2014 Aug; 20(8):886-96. PubMed ID: 24973918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.
    Eeza MNH; Singer R; Höfling C; Matysik J; de Groot HJM; Roβner S; Alia A
    J Alzheimers Dis; 2021; 81(2):797-808. PubMed ID: 33843677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer's disease.
    Wang Y; Wu Z; Bai YT; Wu GY; Chen G
    Mol Neurodegener; 2017 Oct; 12(1):73. PubMed ID: 29017573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive Astrocytes as Drug Target in Alzheimer's Disease.
    Assefa BT; Gebre AK; Altaye BM
    Biomed Res Int; 2018; 2018():4160247. PubMed ID: 29888263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease.
    Salazar AM; Leisgang AM; Ortiz AA; Murtishaw AS; Kinney JW
    Neurobiol Aging; 2021 Jan; 97():129-143. PubMed ID: 33232936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.
    Mitew S; Kirkcaldie MT; Dickson TC; Vickers JC
    Neurobiol Aging; 2013 Oct; 34(10):2341-51. PubMed ID: 23643146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and activity of K
    Boscia F; Pannaccione A; Ciccone R; Casamassa A; Franco C; Piccialli I; de Rosa V; Vinciguerra A; Di Renzo G; Annunziato L
    Neurobiol Aging; 2017 Jun; 54():187-198. PubMed ID: 28390823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation-induced loss of APP function causes GABAergic depletion in recessive familial Alzheimer's disease: analysis of Osaka mutation-knockin mice.
    Umeda T; Kimura T; Yoshida K; Takao K; Fujita Y; Matsuyama S; Sakai A; Yamashita M; Yamashita Y; Ohnishi K; Suzuki M; Takuma H; Miyakawa T; Takashima A; Morita T; Mori H; Tomiyama T
    Acta Neuropathol Commun; 2017 Jul; 5(1):59. PubMed ID: 28760161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender, GABAergic dysfunction and AD.
    Alia A; Roßner S
    Aging (Albany NY); 2018 Nov; 10(12):3636-3637. PubMed ID: 30476903
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroprotective action of diazepam at very low and moderate doses in Alzheimer's disease model rats.
    Pilipenko V; Narbute K; Pupure J; Rumaks J; Jansone B; Klusa V
    Neuropharmacology; 2019 Jan; 144():319-326. PubMed ID: 30408486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's [corrected] disease model.
    Wu Z; Guo Z; Gearing M; Chen G
    Nat Commun; 2014 Jun; 5():4159. PubMed ID: 24923909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
    Devi L; Ohno M
    Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1H NMR metabolomic signatures in five brain regions of the AβPPswe Tg2576 mouse model of Alzheimer's disease at four ages.
    Lalande J; Halley H; Balayssac S; Gilard V; Déjean S; Martino R; Francés B; Lassalle JM; Malet-Martino M
    J Alzheimers Dis; 2014; 39(1):121-43. PubMed ID: 24145382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degeneration of the Suprachiasmatic Nucleus in an Alzheimer's Disease Mouse Model Monitored by in vivo Magnetic Resonance Relaxation Measurements and Immunohistochemistry.
    Roy U; Heredia-Muñoz MT; Stute L; Höfling C; Matysik J; Meijer JH; Roßner S; Alia A
    J Alzheimers Dis; 2019; 69(2):363-375. PubMed ID: 30958376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ¹H- and ¹³C-NMR spectroscopy of Thy-1-APPSL mice brain extracts indicates metabolic changes in Alzheimer's disease.
    Doert A; Pilatus U; Zanella F; Müller WE; Eckert GP
    J Neural Transm (Vienna); 2015 Apr; 122(4):541-50. PubMed ID: 25742870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
    Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
    Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.
    Salcedo C; Wagner A; Andersen JV; Vinten KT; Waagepetersen HS; Schousboe A; Freude KK; Aldana BI
    Neurochem Res; 2021 Oct; 46(10):2676-2686. PubMed ID: 33710537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.